Select a year:

4P-Pharma at Biofit 2018

4P-Pharma Team will be attending the upcoming Biofit 2018 conference in Lille December 4-5th. To learn more about possible partnerships, co-development and our pipeline, contact us via the partnering platform or get in touch with our Business Developer Roselina Lam at roselina(at)4p-pharma.com. Looking forward to meet you there!

Read More

4P-PHARMA, BOOSTING RESEARCH WITH ELSEVIER’S THE HIVE PART II

Our collaboration with Elsevier’s The Hive program continues with a new blog post entry!  In our previous blog post we detailed how Elsevier’s suite of R&D solutions have been helping us in boosting our Research (Read it here). This time we focus on our business model of partnerships and co-development to detect and develop promising technologies&hellip

Read More

4P-Pharma à Parcours France 2018: compte-rendu de la table ronde sur les Biotech en France

Les 4 et 5 octobre derniers se tenait au Palais Brogniart l’édition 2018 de Parcours France, l’événement incontournable de l’économie et business en régions. A cette occasion, Revital Rattenbach, CEO 4P-Pharma, est intervenue lors  d’une table ronde organisée en partenariat avec France Biotech sur le thème ” Biotech en France, un succès possible grâce aux&hellip

Read More

4P-Pharma lost a friend

It is with great sadness that we learned the untimely death of Dr. Yoram Sela on September 26 2018. The 4P-Pharma team extends its deepest sympathies and condolences to his brother Dr. I. Lamensdorf, Dr. Sela’s family and friends. Dr. Sela will be remembered as a tireless innovative mind, a seasoned scientist and recognized expert&hellip

Read More

4P-Pharma, a recognized actor in the ADHD drug pipeline development

4P-Pharma is a recognized actor in the ADHD pipeline drug development. Stimulant abuse and addiction is surging and is becoming a major global health problem. Recently, the CDC released worrisome data on psychostimulants-related overdose death, with a 33,3% increase from 2015-2016*. Last April, at the National Rx Drug Abuse and Heroin Summit, experts warned of&hellip

Read More